8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields

Bioeffects Seen

Authors not listed · 2010

Share:

Power line frequency EMF disrupts melatonin's natural anti-cancer effects in breast cancer cells at exposure levels common in homes.

Plain English Summary

Summary written for general audiences

Researchers exposed breast cancer cells to 50 Hz electromagnetic fields at 1.2 microT (similar to power line levels) for 48 hours and found the EMF disrupted melatonin's anti-cancer effects. Melatonin normally helps suppress breast cancer growth, but the electromagnetic field blocked this protective mechanism at the cellular level.

Why This Matters

This study reveals a concerning mechanism by which everyday EMF exposure might interfere with our body's natural cancer defenses. The 1.2 microT field strength used here is well within the range you might encounter near household appliances or power lines. What makes this particularly troubling is that melatonin serves as one of our primary natural defenses against hormone-positive breast cancers, which represent about 70% of all breast cancer cases. The research demonstrates that EMF doesn't just potentially cause cancer directly, but may also undermine our biological systems that normally prevent cancer development. This adds another layer to the EMF-cancer connection that regulatory agencies have largely ignored.

Exposure Information

A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 50 Hz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 50 HzCell phones~1 GHzWiFi2.4 GHz5G mm28 GHzLogarithmic scale

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2010). Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Show BibTeX
@article{signal_transduction_of_the_melatonin_receptor_mt1_is_disrupted_in_breast_cancer_cells_by_electromagnetic_fields_ce1373,
  author = {Unknown},
  title = {Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields},
  year = {2010},
  doi = {10.1002/bem.20554},
  
}
DOI: 10.1002/bem.20554PubMed: 19882681

Quick Questions About This Study

Yes, this study found that 50 Hz electromagnetic fields at 1.2 microT completely blocked melatonin's ability to suppress cancer-promoting proteins in breast cancer cells, eliminating melatonin's protective anti-estrogenic effects.
The study used 1.2 microT at 50 Hz, which is comparable to EMF levels near household appliances and power lines. This relatively low exposure level was sufficient to completely disrupt melatonin's cancer-fighting mechanisms.
The 50 Hz EMF almost completely eliminated the binding of CREB protein to the BRCA-1 promoter, disrupting normal gene regulation. BRCA-1 is crucial for DNA repair and cancer suppression in breast cells.
Yes, the research shows EMF exposure prevents melatonin from counteracting estrogen's cancer-promoting effects. In EMF-exposed cells, melatonin could no longer reduce the expression of cancer-promoting genes like c-myc and p53.
The study exposed cells for 48 hours and found disrupted melatonin receptor signaling, but didn't test recovery. The MT1 receptor pathway that normally suppresses cancer growth was significantly impaired during EMF exposure.